Although 27% of postmenopausal women were taking HRT in 1999, Kennedy said, that trend began to reverse after the publication ...

Movember is back. Throughout the month of November, men are skipping their razors in favour of sporting a moustache to help ...

Q: My doctor just told me that I’m now considered obese. A week ago, I wasn’t — and I haven’t gained any weight. What’s going ...

Dr. Matthew Rettig and his research team have been awarded a Clinical Cancer Research Center grant from the U.S. Department of Veterans Affairs to establish a new clinical cancer research center that ...

With a favourable safety profile and consistent activity across tumour types, agenT-797 is now poised to enter phase 2 trials. MiNK believes the therapy could redefine treatment for patients with ...

New review of research shows benefits outweigh risks for women who start treatment within 10 years of menopause onset After [ ...

Durable survival and deep, lasting remissions in checkpoint-refractory, heavily pretreated cancers with median OS of ~23 months with agenT-797 ...

We are conducting a two-part exploration of Benign Prostatic Hyperplasia (BPH), reviewing both the historical and the forward ...

Purdue Pharma L.P. ("Purdue") today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to its pipeline drug tinostamustine for the treatment of ...

Positron emission tomography (PET), when combined with computed tomography (CT), has become one of the most powerful ...

Recent studies have demonstrated that excess sugar can cause depression in non-diabetics. For example, data from the National ...